The Directors of Queensland Bauxite Ltd (ASX:QBL) present their report together with the consolidated financial statements of the Group comprising Queensland Bauxite Limited ("the Company" or "QBL") and its subsidiaries, for the financial year ended 30 June 2017 and the independent auditors report thereon.
Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.
Queensland Bauxite Limited (ASX:QBL) is proud to report on Medical Cannabis Limited (MCL)'s progress with a major milestone achieved this week. 20 tonnes of certified low THC hemp seed for sowing has been secured so that MCL will be able to grow enough low THC cannabis.
Regeneus Ltd (ASX:RGS) , a clinical-stage regenerative medicine company, today announced that a preclinical post-operative pain study has shown that topical application of Sygenus, has significantly greater and longer lasting analgesic effect than an injection of morphine.
Queensland Bauxite Limited (ASX:QBL) is pleased to announce preliminary findings in relation to cannabinoid testing performed by its subsidiary Medical Cannabis Limited of some of MCL's low THC Cannabis cultivars. (THC is tetrahydrocannabinol Delta 9, a medical compound produced by Cannabis plants).
Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre in 2015.
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the work programme intended under the MDL.
